0.20Open0.20Pre Close0 Volume79 Open Interest20.00Strike Price0.00Turnover60.43%IV19.53%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1576Delta0.0930Gamma84.50Leverage Ratio-0.0135Theta0.0016Rho13.32Eff Leverage0.0103Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet